GlassScriptPhysician profile
Prabal K Guha
NPI 1043277304
$14,294.42
in general payments reported to CMS, 2019-2025
43 companies · $2,584 in 2025
The $2,584 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,441 · 2020: $477 · 2021: $470 · 2022: $1,565 · 2023: $4,600 · 2024: $2,158 · 2025: $2,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,249 · Travel and Lodging: $4,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,249.00 |
| Travel and Lodging | $4,092.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,953.65 | 2019-2025 | Amplatzer Amulet, Aveir, Pressurewire |
| Boston Scientific Corporation | $2,356.17 | 2019-2025 | Watchman Access System, Rhythmia Mapping System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $996.78 | 2019-2025 | Lifevest |
| Biotronik INC. | $878.42 | 2024 | Selectra, Solia |
| Biosense Webster, INC. | $570.25 | 2019-2024 | Carto 3, Nuvision Ice Catheter, Na |
| Novartis Pharmaceuticals Corporation | $500.26 | 2019-2025 | |
| Cvrx, INC. | $474.22 | 2024-2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $354.62 | 2019-2025 | Farxiga |
| Janssen Pharmaceuticals, INC | $330.47 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $238.63 | 2021-2025 | Verquvo |
| Pfizer INC. | $182.08 | 2019-2024 | |
| Abiomed | $141.68 | 2025 | |
| Atricure, INC. | $141.59 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Impulse Dynamics (USA) INC. | $140.76 | 2025 | Optimizer |
| E.R. Squibb & Sons, L.L.C. | $137.73 | 2019-2025 | Eliquis |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabal Guha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.